The Readout Loud
Un pódcast de STAT - Jueves
350 Episodo
-
228: A surprise success in Alzheimer's and how FDA history seeded modern controversy
Publicado: 29/9/2022 -
227: Biden's Covid declaration, twilight of the SPAC, & genome editing 2.0
Publicado: 22/9/2022 -
226: Pharma's telehealth gold mine, the return of the biotech IPO, & a merger deferred
Publicado: 15/9/2022 -
225: Illumina's $8 billion limbo, a new treatment for ALS, & Emirati biotech funding
Publicado: 8/9/2022 -
224: The anti-aging research boom, the Godfather of biotech, & the future of Biogen
Publicado: 1/9/2022 -
223: Fauci's non-retirement, grading biotech VCs, & a bellwether IPO
Publicado: 25/8/2022 -
222: Private equity in autism care, a watershed FDA approval, & the future of ALS treatment
Publicado: 18/8/2022 -
221: Big egos in Big Science, the return of Merger Monday, & the fallout over drug pricing
Publicado: 11/8/2022 -
220: The last-minute push for drug pricing reform, Alnylam's success, and Sarepta's gamble
Publicado: 4/8/2022 -
219: Helen Branswell on monkeypox, plus: an FDA controversy and fake Alzheimer's data
Publicado: 28/7/2022 -
218: Well-paid CEOs, behind the scenes at Moderna, & Biogen's CEO search
Publicado: 21/7/2022 -
217: CRISPR for the heart, biotech's recovery, & what it means to be a 'hot girl'
Publicado: 14/7/2022 -
216: VC malaise, FDA confusion, & yet another Alzheimer's debate
Publicado: 7/7/2022 -
215: Medical privacy post-Roe, fixing clinical trials, & the next Covid vaccines
Publicado: 30/6/2022 -
214: Juul's doomsday, Merck's buyout plans, & the next Theranos verdict
Publicado: 23/6/2022 -
213: How the Fed affects biotech, Paul Offit on vaccines for kids, & another Alzheimer's setback
Publicado: 16/6/2022 -
212: Applause-worthy cancer data, the long wait for Novavax, & the next FDA controversy
Publicado: 9/6/2022 -
211: Biotech's catch-22, a $100 genome, & dealing with monkeypox
Publicado: 2/6/2022 -
210: Covid vaccines for the youngest kids, ASCO preview, & a biotech CEO’s arrest on murder charges
Publicado: 26/5/2022 -
Episode 209: Mysterious infections, dwindling Covid funds, & Shkreli out of prison
Publicado: 19/5/2022
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.